State Street’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2,195,476
| Closed | -$42.7M | – | 3856 |
|
|
2018
Q1 | $42.7M | Sell |
2,195,476
-315,186
| -13% | -$6.19M | ﹤0.01% | 1524 |
|
|
2017
Q4 | $41.8M | Buy |
2,510,662
+97,828
| +4% | +$1.79M | ﹤0.01% | 1542 |
|
|
2017
Q3 | $49M | Sell |
2,412,834
-223,687
| -8% | -$4.28M | ﹤0.01% | 1383 |
|
|
2017
Q2 | $42.5M | Sell |
2,636,521
-155,321
| -6% | -$2.29M | ﹤0.01% | 1463 |
|
|
2017
Q1 | $35.3M | Buy |
2,791,842
+456,191
| +20% | +$5.51M | ﹤0.01% | 1538 |
|
|
2016
Q4 | $30.9M | Buy |
2,335,651
+271,533
| +13% | +$4.64M | ﹤0.01% | 1579 |
|
|
2016
Q3 | $48.9M | Buy |
2,064,118
+308,509
| +18% | +$8.29M | ﹤0.01% | 1225 |
|
|
2016
Q2 | $50.6M | Buy |
1,755,609
+14,623
| +0.8% | +$477K | 0.01% | 1180 |
|
|
2016
Q1 | $55.7M | Sell |
1,740,986
-106,610
| -6% | -$3.75M | 0.01% | 1123 |
|
|
2015
Q4 | $79M | Sell |
1,847,596
-96,657
| -5% | -$3.86M | 0.01% | 932 |
|
|
2015
Q3 | $68.5M | Sell |
1,944,253
-206,815
| -10% | -$9.32M | 0.01% | 993 |
|
|
2015
Q2 | $98.8M | Sell |
2,151,068
-147,585
| -6% | -$7M | 0.01% | 885 |
|
|
2015
Q1 | $108M | Sell |
2,298,653
-151,314
| -6% | -$6.02M | 0.01% | 851 |
|
|
2014
Q4 | $77.6M | Sell |
2,449,967
-272,255
| -10% | -$7.97M | 0.01% | 981 |
|
|
2014
Q3 | $64.5M | Buy |
2,722,222
+374,025
| +16% | +$9.58M | 0.01% | 1041 |
|
|
2014
Q2 | $70.4M | Buy |
2,348,197
+255,878
| +12% | +$6.9M | 0.01% | 1041 |
|
|
2014
Q1 | $55.3M | Buy |
2,092,319
+205,918
| +11% | +$5.15M | 0.01% | 1152 |
|
|
2013
Q4 | $47.4M | Sell |
1,886,401
-173,874
| -8% | -$3.88M | 0.01% | 1222 |
|
|
2013
Q3 | $42.3M | Sell |
2,060,275
-223,316
| -10% | -$4.61M | 0.01% | 1273 |
|
|
2013
Q2 | $45.6M | Buy |
+2,283,591
| New | +$40.5M | 0.01% | 1178 |
|
State Street's IPXL Position: Q2 2018 in Review
State Street sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 2,195,476 shares — an estimated $42.7M sold.
State Street first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $108M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- State Street reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- State Street sold 2,195,476 Impax Laboratories, Inc. shares in Q2 2018, an estimated $42.7M.
- State Street first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- State Street's Impax Laboratories, Inc. position peaked at $108M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on State Street's 13F filing for Q2 2018, filed 14 Aug 2018.